Galecto, Inc. (GLTO)

Latest Insider Confidence Score

2026Q1

44.7
Bearish

Company insider confidence (by quarter)

2020Q4 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Kiselak Tomas — 26,801,000 Nov 17, 2025
Fairmount Funds Management LLC — 26,801,000 Nov 17, 2025
Fairmount Healthcare Fund II L.P. — 26,801,000 Nov 17, 2025
Harwin Peter Evan — 26,801,000 Nov 17, 2025
Fairmount Healthcare Co-Invest V L.P. — 26,801,000 Nov 17, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 9, 2026 Feb 12, 2026 Bruno Julianne Director Neutral 52.5 - 0.00% ✗ -
Feb 9, 2026 Feb 12, 2026 Fairmount Funds Management LLC Director Neutral 52.5 - 0.00% ✗ -
Jan 5, 2026 Jan 26, 2026 Sattarzadeh Sherwin COO Neutral 90.0 +190,376 100.00% ✗ -
Jan 26, 2026 Sattarzadeh Sherwin COO Neutral 52.5 - 0.00% ✗ -
Jan 5, 2026 Jan 7, 2026 Hewes L. Becker Chief Medical Officer Neutral 90.0 +264,629 100.00% ✗ -
Jan 7, 2026 Hewes L. Becker Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 2, 2026 Jan 6, 2026 Schambye Hans T. CEO Sell 26.3 -700 -13.01% ✗ $15K
Jan 2, 2026 Jan 6, 2026 Winslow Garrett General Counsel Sell 27.5 -255 -12.09% ✗ $5.5K
Jan 2, 2026 Jan 6, 2026 Firmani Lori CFO Sell 27.5 -135 -12.66% ✗ $2.9K
Nov 17, 2025 Fairmount Funds Management LLC Director Neutral 52.5 - 0.00% ✗ -
Nov 17, 2025 CAIN CHRISTOPHER W. Director Neutral 52.5 - 0.00% ✗ -
Nov 17, 2025 Bruno Julianne Director Neutral 52.5 - 0.00% ✗ -
Jul 3, 2025 Jul 8, 2025 Schambye Hans T. CEO Sell 27.5 -735 -15.45% ✗ $2.5K
Jul 3, 2025 Jul 8, 2025 Winslow Garrett General Counsel Sell 27.5 -260 -15.39% ✗ $881.4
Jul 3, 2025 Jul 8, 2025 Firmani Lori CFO Sell 27.5 -147 -17.52% ✗ $498.3
Jun 18, 2025 Jun 20, 2025 Dallas Jayson Donald Alexander Director Neutral 52.5 - 0.00% ✗ -
Jun 18, 2025 Jun 20, 2025 Munshi Amit Director Neutral 52.5 - 0.00% ✗ -
Jun 18, 2025 Jun 20, 2025 Shapiro David Director Neutral 52.5 - 0.00% ✗ -
Jun 18, 2025 Jun 20, 2025 Prener Anne Director Neutral 52.5 - 0.00% ✗ -
Jun 18, 2025 Jun 20, 2025 WECHSLER AMY B Director Neutral 52.5 - 0.00% ✗ -
Jun 18, 2025 Jun 20, 2025 GOLDFISCHER CARL Director Neutral 52.5 - 0.00% ✗ -
Jan 3, 2025 Jan 7, 2025 Winslow Garrett General Counsel Sell 27.5 -471 -31.82% ✗ $2.6K
Jan 3, 2025 Jan 7, 2025 Firmani Lori CFO Sell 27.5 -261 -35.95% ✗ $1.5K
Jan 3, 2025 Jan 7, 2025 Kronmiller Matthew EVP Strategy and CBO Neutral 52.5 - 0.00% ✗ -
Jan 3, 2025 Jan 7, 2025 Schambye Hans T. CEO Sell 27.5 -1,341 -28.30% ✗ $7.5K
Oct 11, 2024 Oct 15, 2024 WECHSLER AMY B Director Neutral 52.5 - 0.00% ✗ -
Oct 15, 2024 WECHSLER AMY B Director Neutral 52.5 - 0.00% ✗ -
Oct 9, 2024 Oct 11, 2024 Kronmiller Matthew EVP Strategy and CBO Neutral 52.5 - 0.00% ✗ -
Oct 9, 2024 Oct 11, 2024 Firmani Lori CFO Neutral 52.5 - 0.00% ✗ -
Oct 9, 2024 Oct 11, 2024 Winslow Garrett General Counsel Neutral 52.5 - 0.00% ✗ -
Oct 9, 2024 Oct 11, 2024 Schambye Hans T. CEO Neutral 52.5 - 0.00% ✗ -
Oct 11, 2024 Kronmiller Matthew EVP Strategy and CBO Neutral 52.5 - 0.00% ✗ -
Aug 16, 2024 Firmani Lori CFO Neutral 52.5 - 0.00% ✗ -
Jun 20, 2024 Jun 21, 2024 Prener Anne Director Neutral 52.5 - 0.00% ✗ -
Jun 20, 2024 Jun 21, 2024 Munshi Amit Director Neutral 52.5 - 0.00% ✗ -
Jun 20, 2024 Jun 21, 2024 GOLDFISCHER CARL Director Neutral 52.5 - 0.00% ✗ -
Jun 20, 2024 Jun 21, 2024 Shapiro David Director Neutral 52.5 - 0.00% ✗ -
Jun 20, 2024 Jun 21, 2024 Dallas Jayson Donald Alexander Director Neutral 52.5 - 0.00% ✗ -
Jan 3, 2024 Jan 5, 2024 Schambye Hans T. CEO Neutral 52.5 - 0.00% ✗ -
Jan 3, 2024 Jan 5, 2024 Winslow Garrett General Counsel Neutral 52.5 - 0.00% ✗ -
Jan 3, 2024 Jan 5, 2024 Freve Jonathan CFO Neutral 52.5 - 0.00% ✗ -
Aug 15, 2023 Aug 17, 2023 ORBIMED ADVISORS LLC 10% Owner Sell 20.0 -822,680 -26.87% ✗ $617K
Jul 31, 2023 Aug 2, 2023 ORBIMED ADVISORS LLC 10% Owner Sell 20.0 -209,400 -6.29% ✗ $628.2K
Jul 25, 2023 Jul 27, 2023 ORBIMED ADVISORS LLC 10% Owner Sell 22.5 -39,200 -1.16% ✗ $114.5K
Jul 13, 2023 Jul 17, 2023 ORBIMED ADVISORS LLC 10% Owner Sell 20.0 -194,700 -5.46% ✗ $467.3K
Jun 14, 2023 Jun 15, 2023 Shapiro David Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2023 Jun 15, 2023 Prener Anne Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2023 Jun 15, 2023 Munshi Amit Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2023 Jun 15, 2023 GOLDFISCHER CARL Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2023 Jun 15, 2023 Dallas Jayson Donald Alexander Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2023 Jun 15, 2023 Khuong Chau Quang Director Neutral 52.5 - 0.00% ✗ -
Apr 13, 2023 Apr 17, 2023 ORBIMED ADVISORS LLC 10% Owner Sell 32.5 -68,481 -0.63% ✗ $128.3K
Apr 10, 2023 Apr 12, 2023 ORBIMED ADVISORS LLC 10% Owner Sell 32.5 -67,537 -0.61% ✗ $121.4K
Apr 5, 2023 Apr 7, 2023 ORBIMED ADVISORS LLC 10% Owner Sell 22.5 -102,630 -1.37% ✗ $222K
Jan 4, 2023 Jan 5, 2023 Schambye Hans T. CEO Neutral 52.5 - 0.00% ✗ -
Jan 4, 2023 Jan 5, 2023 Oestreich Stephanie Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Jan 4, 2023 Jan 5, 2023 Pedersen Anders COO Neutral 52.5 - 0.00% ✗ -
Jan 4, 2023 Jan 5, 2023 Freve Jonathan CFO Neutral 52.5 - 0.00% ✗ -
Jan 4, 2023 Jan 5, 2023 Winslow Garrett General Counsel Neutral 52.5 - 0.00% ✗ -
Jan 4, 2023 Jan 5, 2023 Lindmark Bertil Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jun 14, 2022 Jun 15, 2022 Munshi Amit Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2022 Jun 15, 2022 Shapiro David Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2022 Jun 15, 2022 Prener Anne Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2022 Jun 15, 2022 Khuong Chau Quang Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2022 Jun 15, 2022 GOLDFISCHER CARL Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2022 Jun 15, 2022 Dallas Jayson Donald Alexander Director Neutral 52.5 - 0.00% ✗ -
Mar 22, 2022 Mar 23, 2022 Lindmark Bertil Chief Medical Officer Buy 91.3 +14,604 730.20% ✗ $31.5K
Mar 22, 2022 Mar 23, 2022 Schambye Hans T. CEO Buy 91.3 +5,000 10.54% ✗ $10.8K
Feb 15, 2022 Feb 15, 2022 Oestreich Stephanie Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Jan 4, 2022 Jan 6, 2022 Schambye Hans T. CEO Neutral 52.5 - 0.00% ✗ -
Jan 4, 2022 Jan 6, 2022 Lindmark Bertil Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 4, 2022 Jan 6, 2022 Pedersen Anders COO Neutral 52.5 - 0.00% ✗ -
Jan 4, 2022 Jan 6, 2022 Winslow Garrett General Counsel Neutral 52.5 - 0.00% ✗ -
Jan 4, 2022 Jan 6, 2022 Freve Jonathan CFO Neutral 52.5 - 0.00% ✗ -
Jan 5, 2022 Oestreich Stephanie Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Dec 3, 2021 Dec 6, 2021 Winslow Garrett General Counsel Buy 90.0 +2,000 100.00% ✗ $5K
Dec 3, 2021 Dec 6, 2021 Freve Jonathan CFO Buy 90.0 +4,000 50.00% ✗ $10K
Nov 17, 2021 Nov 19, 2021 Khuong Chau Quang Director Neutral 52.5 - 0.00% ✗ -
Nov 17, 2021 Nov 19, 2021 GOLDFISCHER CARL Director Neutral 52.5 - 0.00% ✗ -
Nov 9, 2021 Nov 10, 2021 Schambye Hans T. CEO Buy 91.3 +4,500 10.48% ✗ $15.8K
Nov 8, 2021 Nov 9, 2021 Freve Jonathan CFO Buy 91.3 +3,000 60.00% ✗ $10.2K
Aug 18, 2021 Aug 19, 2021 Freve Jonathan CFO Buy 91.3 +3,000 150.00% ✗ $11.8K
Jun 28, 2021 Jun 28, 2021 Lindmark Bertil Chief Medical Officer Buy 91.3 +2,000 100.00% ✗ $10.5K
Jun 24, 2021 Jun 24, 2021 Schambye Hans T. CEO Buy 86.3 +3,000 7.51% ✗ $15.3K
Jun 23, 2021 Jun 23, 2021 Freve Jonathan CFO Buy 90.0 +2,000 100.00% ✗ $9.5K
Jun 23, 2021 Jun 23, 2021 Winslow Garrett General Counsel Buy 90.0 +2,000 100.00% ✗ $9.6K
Jun 15, 2021 Jun 16, 2021 Winslow Garrett General Counsel Neutral 52.5 - 0.00% ✗ -
May 26, 2021 May 28, 2021 Dallas Jayson Donald Alexander Director Neutral 52.5 - 0.00% ✗ -
May 26, 2021 May 28, 2021 Prener Anne Director Neutral 52.5 - 0.00% ✗ -
May 26, 2021 May 28, 2021 GOLDFISCHER CARL Director Neutral 52.5 - 0.00% ✗ -
May 26, 2021 May 28, 2021 Khuong Chau Quang Director Neutral 52.5 - 0.00% ✗ -
May 11, 2021 Winslow Garrett General Counsel Neutral 52.5 - 0.00% ✗ -
Jan 8, 2021 Jan 8, 2021 Prener Anne Director Neutral 52.5 - 0.00% ✗ -
Jan 8, 2021 Prener Anne Director Neutral 52.5 - 0.00% ✗ -
Jan 5, 2021 Jan 7, 2021 Schambye Hans T. CEO Neutral 52.5 - 0.00% ✗ -
Jan 5, 2021 Jan 7, 2021 Pedersen Anders COO Neutral 52.5 - 0.00% ✗ -
Jan 5, 2021 Jan 7, 2021 Freve Jonathan CFO Neutral 52.5 - 0.00% ✗ -
Jan 5, 2021 Jan 7, 2021 Lindmark Bertil Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Nov 19, 2020 Nov 23, 2020 Dallas Jayson Donald Alexander Director Neutral 52.5 - 0.00% ✗ -
Nov 23, 2020 Dallas Jayson Donald Alexander Director Neutral 52.5 - 0.00% ✗ -